ID   MCA R63
AC   CVCL_4551
SY   MCA-R63; R63; R-63
DR   CLO; CLO_0008720
DR   CLDB; cl5251
DR   IZSLER; BS Hy 45
DR   Wikidata; Q54949058
RX   Patent=US4956452;
RX   Patent=US5064646;
RX   PubMed=2848486;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9490.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Infectious bursal disease virus (IBDV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
RX   Patent=US4956452;
RA   Snyder D.B., Marquardt W.W., Gorham S.L., Lana D.P.;
RT   "Monoclonal antibody which neutralizes multiple strains of infectious
RT   bursal disease virus.";
RL   Patent number US4956452, 11-Sep-1990.
//
RX   Patent=US5064646;
RA   Snyder D.B.;
RT   "Novel infectious bursal disease virus.";
RL   Patent number US5064646, 12-Nov-1991.
//
RX   PubMed=2848486; DOI=10.2307/1590923;
RA   Snyder D.B., Lana D.P., Cho B.R., Marquardt W.W.;
RT   "Group and strain-specific neutralization sites of infectious bursal
RT   disease virus defined with monoclonal antibodies.";
RL   Avian Dis. 32:527-534(1988).
//